$20.78
-0.04-0.19%
Pre-Market: 6:12 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Kiniksa Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.